| 1 |
Tang C, Cai J, Yin XM, et al. Mitochondrial quality control in kidney injury and repair[J]. Nat Rev Nephrol, 2021, 17 (5): 299-318.
|
| 2 |
Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney[J]. Nat Rev Nephrol, 2017, 13 (10): 629-646.
|
| 3 |
Larson-Casey JL, He C, Carter AB. Mitochondrial quality control in pulmonary fibrosis[J]. Redox Biol, 2020, 33: 101426.
|
| 4 |
张丽敏，张志明，李兴芳，等.巨噬细胞程序性死亡在急性肺损伤/急性呼吸窘迫综合征中的研究进展[J/OL].中华危重症医学杂志（电子版），2024，17（2）：148-154.
|
| 5 |
Bos LDJ, Ware LB. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes[J]. Lancet, 2022, 400 (10358): 1145-1156.
|
| 6 |
Cho HY, Kleeberger SR. Mitochondrial biology in airway pathogenesis and the role of NRF2[J]. Arch Pharm Res, 2020, 43 (3): 297-320.
|
| 7 |
Chan DC. Mitochondrial fusion and fission in mammals[J]. Annu Rev Cell Dev Biol, 2006, 22: 79-99.
|
| 8 |
Beikoghli Kalkhoran S, Kararigas G. Oestrogenic regulation of mitochondrial dynamics[J]. Int J Mol Sci, 2022, 23 (3): 1118.
|
| 9 |
Chang X, Li Y, Cai C, et al. Mitochondrial quality control mechanisms as molecular targets in diabetic heart[J]. Metabolism, 2022, 137: 155313.
|
| 10 |
Casellas-Díaz S, Larramona-Arcas R, Riqué-Pujol G, et al. Mfn2 localization in the ER is necessary for its bioenergetic function and neuritic development[J]. EMBO Rep, 2021, 22 (9): e51954.
|
| 11 |
Ma Y, Wang L, Jia R. The role of mitochondrial dynamics in human cancers[J]. Am J Cancer Res, 2020, 10 (5): 1278-1293.
|
| 12 |
Sun M, Zeng Z, Xu G, et al. Promoting mitochondrial dynamic equilibrium attenuates sepsis-induced acute lung injury by inhibiting proinflammatory polarization of alveolar macrophages[J]. Shock, 2023, 60 (4): 603-612.
|
| 13 |
Li N, Liu B, Xiong R, et al. HDAC3 deficiency protects against acute lung injury by maintaining epithelial barrier integrity through preserving mitochondrial quality control[J]. Redox Biol, 2023, 63: 102746.
|
| 14 |
Chung KP, Hsu CL, Fan LC, et al. Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis[J]. Nat Commun, 2019, 10 (1): 3390.
|
| 15 |
Jiang J, Wang J, Li C, et al. Hyperoxia induces alveolar epithelial cell apoptosis by regulating mitochondrial function through small mothers against decapentaplegic 3 (SMAD3) and extracellular signal-regulated kinase 1/2 (ERK1/2)[J]. Bioengineered, 2022, 13 (1): 242-252.
|
| 16 |
Shi J, Yu J, Zhang Y, et al. PI3K/Akt pathway-mediated HO-1 induction regulates mitochondrial quality control and attenuates endotoxin-induced acute lung injury[J]. Lab Invest, 2019, 99 (12): 1795-1809.
|
| 17 |
Zhou H, Ren J, Toan S, et al. Role of mitochondrial quality surveillance in myocardial infarction: from bench to bedside[J]. Ageing Res Rev, 2021, 66: 101250.
|
| 18 |
Wang S, Long H, Hou L, et al. The mitophagy pathway and its implications in human diseases[J]. Signal Transduct Target Ther, 2023, 8 (1): 304.
|
| 19 |
Yang HH, Jiang HL, Tao JH, et al. Mitochondrial citrate accumulation drives alveolar epithelial cell necroptosis in lipopolysaccharide-induced acute lung injury[J]. Exp Mol Med, 2022, 54 (11): 2077-2091.
|
| 20 |
Li G, Fu T, Wang W, et al. Pretreatment with kahweol attenuates sepsis-induced acute lung injury via improving mitochondrial homeostasis in a CaMKKII/AMPK-dependent pathway[J]. Mol Nutr Food Res, 2023, 67 (19): e2300083.
|
| 21 |
Letsiou E, Sammani S, Wang H, et al. Parkin regulates lipopolysaccharide-induced proinflammatory responses in acute lung injury[J]. Transl Res, 2017, 181: 71-82.
|
| 22 |
Zhang C, Gao X, Li M, et al. The role of mitochondrial quality surveillance in skin aging: focus on mitochondrial dynamics, biogenesis and mitophagy[J]. Ageing Res Rev, 2023, 87: 101917.
|
| 23 |
Peng X, Chen S, Wang Y, et al. SGLT2i reduces renal injury by improving mitochondrial metabolism and biogenesis[J]. Mol Metab, 2022: 101613.
|
| 24 |
Chen Y, Guo M, Xie K, et al. Progranulin promotes regulatory T cells plasticity by mitochondrial metabolism through AMPK/PGC-1α pathway in ARDS[J]. Clin Immunol, 2024, 261: 109940.
|
| 25 |
Zhang N, Li P, Lin H, et al. IL-10 ameliorates PM2.5-induced lung injury by activating the AMPK/SIRT1/PGC-1α pathway[J]. Environ Toxicol Pharmacol, 2021, 86: 103659.
|
| 26 |
Caporarello N, Meridew JA, Jones DL, et al. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state[J]. Thorax, 2019, 74 (8): 749-760.
|
| 27 |
Mannam P, Shinn AS, Srivastava A, et al. MKK3 regulates mitochondrial biogenesis and mitophagy in sepsis-induced lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2014, 306 (7): L604-L619.
|
| 28 |
Harrington JS, Ryter SW, Plataki M, et al. Mitochondria in health, disease, and aging[J]. Physiol Rev, 2023, 103 (4): 2349-2422.
|
| 29 |
Ten VS, Ratner V. Mitochondrial bioenergetics and pulmonary dysfunction: current progress and future directions[J]. Paediatr Respir Rev, 2020, 34: 37-45.
|
| 30 |
Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, et al. Regulated necrosis: the expanding network of non-apoptotic cell death pathways[J]. Nat Rev Mol Cell Biol, 2014, 15 (2): 135-147.
|
| 31 |
Tojo K, Tamada N, Nagamine Y, et al. Enhancement of glycolysis by inhibition of oxygen-sensing prolyl hydroxylases protects alveolar epithelial cells from acute lung injury[J]. FASEB J, 2018, 32 (4): 2258-2268.
|
| 32 |
Jackson MV, Morrison TJ, Doherty DF, et al. Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS[J]. Stem Cells, 2016, 34 (8): 2210-2223.
|
| 33 |
Beurskens CJ, Aslami H, Kuipers MT, et al. Induced hypothermia is protective in a rat model of pneumococcal pneumonia associated with increased adenosine triphosphate availability and turnover*[J]. Crit Care Med, 2012, 40 (3): 919-926.
|
| 34 |
Sharma A, Liaw K, Sharma R, et al. Targeting mitochondrial dysfunction and oxidative stress in activated microglia using dendrimer-based therapeutics[J]. Theranostics, 2018, 8 (20): 5529-5547.
|
| 35 |
Lowes DA, Thottakam BM, Webster NR, et al. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis[J]. Free Radic Biol Med, 2008, 45 (11): 1559-1565.
|
| 36 |
Zhan P, Lu X, Li Z, et al. Mitoquinone alleviates bleomycin-induced acute lung injury via inhibiting mitochondrial ROS-dependent pulmonary epithelial ferroptosis[J]. Int Immunopharmacol, 2022, 113 (Pt A): 109359.
|
| 37 |
Li N, Xiong R, Li G, et al. A novel mechanism for the protection against acute lung injury by melatonin: mitochondrial quality control of lung epithelial cells is preserved through SIRT3-dependent deacetylation of SOD2[J]. Cell Mol Life Sci, 2022, 79 (12): 610.
|
| 38 |
Selvaraj V, Nepal N, Rogers S, et al. Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles[J]. Biomaterials, 2015, 59: 160-171.
|
| 39 |
Supinski GS, Schroder EA, Callahan LA. Mitochondria and critical illness[J]. Chest, 2020, 157 (2): 310-322.
|
| 40 |
Zhu X, Wang F, Lei X, et al. Resveratrol alleviates alveolar epithelial cell injury induced by hyperoxia by reducing apoptosis and mitochondrial dysfunction[J]. Exp Biol Med (Maywood), 2021, 246 (5): 596-606.
|
| 41 |
Zhang TG, Miao CY. Mitochondrial transplantation as a promising therapy for mitochondrial diseases[J]. Acta Pharm Sin B, 2023, 13 (3): 1028-1035.
|
| 42 |
Cowan DB, Yao R, Thedsanamoorthy JK, et al. Transit and integration of extracellular mitochondria in human heart cells[J]. Sci Rep, 2017, 7 (1): 17450.
|
| 43 |
Sun CK, Lee FY, Kao YH, et al. Systemic combined melatonin-mitochondria treatment improves acute respiratory distress syndrome in the rat[J]. J Pineal Res, 2015, 58 (2): 137-150.
|
| 44 |
Moskowitzova K, Orfany A, Liu K, et al. Mitochondrial transplantation enhances murine lung viability and recovery after ischemia-reperfusion injury[J]. Am J Physiol Lung Cell Mol Physiol, 2020, 318 (1): L78-L88.
|
| 45 |
Dutra Silva J, Su Y, Calfee CS, et al. Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS[J]. Eur Respir J, 2021, 58 (1): 2002978.
|
| 46 |
Jiang Q, Yin J, Chen J, et al. Mitochondria-targeted antioxidants: a step towards disease treatment[J]. Oxid Med Cell Longev, 2020, 2020: 8837893.
|
| 47 |
Tabish TA, Hamblin MR. Mitochondria-targeted nanoparticles (mitoNANO): an emerging therapeutic shortcut for cancer[J]. Biomater Biosyst, 2021, 3: 100023.
|
| 48 |
Zhong G, Venkatesan JK, Madry H, et al. Advances in human mitochondria-based therapies[J]. Int J Mol Sci, 2022, 24 (1): 608.
|